P16 Expression in Squamous Cell Carcinomas of Cervix and Bladder
Authors:
- Jennifer Chapman-FredricksJCJennifer Chapman-Fredricks
- Carmen Gomez-FernandezCGCarmen Gomez-Fernandez
- Parvin Ganjei-AzarPGParvin Ganjei-Azar
- Merce JordaMJMerce Jorda
- 1 July 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 18 (4) , 344-347
Abstract
Context/Objective p16 is a widely used immunohistochemical marker in gynecologic pathology. Strong and diffuse cytoplasmic and nuclear expression of p16 in squamous cell carcinomas (SCC) of the female genital tract is strongly associated with high-risk human papilloma virus infection and neoplasms of cervical origin. However, p16 can be expressed in other neoplasms and in several normal human tissues. Occasionally, SCCs may involve both uterine cervix and urinary bladder. Accurate identification of the site of origin in such cases has therapeutic and prognostic implications. We investigate the potential value of p16 expression in this distinction. Design We reviewed 74 SCCs, 38 (51%) from urinary bladder and 36 (49%) from uterine cervix obtained between 2003 and 2008. Of the 38 cases of bladder carcinoma, 21 occurred in females and 17 in males. Immunohistochemical analysis for p16 (DAKO M7247, clone 484, dilution of 1:50) expression was done in all cases using the labeled streptavidin-biotin method. Result Strong and diffuse nuclear and cytoplasmic p16 positivity was observed in 45 cases (61%). Of the 38 SCCs of urinary bladder, 14 (37%) expressed p16 (8 males, 6 females). Of the 36 SCCs of uterine cervix, 31 (86%) were positive for p16. Conclusions (1) The majority of SCCs of uterine cervix express p16. (2) More than a third of urinary bladder SCCs express p16. (3) SCCs of urinary bladder express p16 independent of gender. (4) p16 immunohistochemical expression alone cannot be used to discriminate between SCCs arising from uterine cervix versus urinary bladder.Keywords
This publication has 11 references indexed in Scilit:
- Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesionsCancer, 2008
- Squamous Cell Carcinoma of the Bladder: A Clinicopathologic Analysis of 45 CasesAmerican Journal of Surgical Pathology, 2007
- Immunohistochemical Expression of p16(INK4A) in Normal Uterine Cervix, Nonneoplastic Epithelial Lesions, and Low-grade Squamous Intraepithelial LesionsJournal of Lower Genital Tract Disease, 2007
- p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancerBiochemical and Biophysical Research Communications, 2006
- p16 Expression in the Female Genital Tract and Its Value in DiagnosisAdvances in Anatomic Pathology, 2006
- P16 Immunoreactivity Is an Independent Predictor of Tumor Progression in Minimally Invasive Urothelial Bladder CarcinomaEuropean Urology, 2005
- Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasiaHuman Pathology, 2004
- Expression of p16, Rb, and p53 Proteins in Squamous Cell Carcinomas of the Anorectal Region Harboring Human Papillomavirus DNALaboratory Investigation, 2003
- Expression of p16 Protein Identifies a Distinct Entity of Tonsillar Carcinomas Associated with Human PapillomavirusThe American Journal of Pathology, 2003
- p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial NeoplasiaAmerican Journal of Surgical Pathology, 2002